Cyclacel Pharmaceuticals, Inc. Quarterly Return On Assets in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Cyclacel Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q2 2024.
  • Cyclacel Pharmaceuticals, Inc. Return On Assets for the quarter ending June 30, 2024 was -196 %, a 105% decline year-over-year.
  • Cyclacel Pharmaceuticals, Inc. annual Return On Assets for 2023 was -148 %, a 137% decline from 2022.
  • Cyclacel Pharmaceuticals, Inc. annual Return On Assets for 2022 was -62.5 %, a 57.9% decline from 2021.
  • Cyclacel Pharmaceuticals, Inc. annual Return On Assets for 2021 was -39.6 %, a 24.4% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -196 -101 -105% Apr 1, 2024 Jun 30, 2024
Q1 2024 -177 -99.7 -129% Jan 1, 2024 Mar 31, 2024
Q4 2023 -148 -85.7 -137% Oct 1, 2023 Dec 31, 2023
Q3 2023 -123 -73.2 -146% Jul 1, 2023 Sep 30, 2023
Q2 2023 -95.8 -50.8 -113% Apr 1, 2023 Jun 30, 2023
Q1 2023 -77.5 -33.9 -77.6% Jan 1, 2023 Mar 31, 2023
Q4 2022 -62.5 -22.9 -57.9% Oct 1, 2022 Dec 31, 2022
Q3 2022 -50.1 -14.2 -39.6% Jul 1, 2022 Sep 30, 2022
Q2 2022 -45.1 -11.4 -33.7% Apr 1, 2022 Jun 30, 2022
Q1 2022 -43.6 -14.1 -47.8% Jan 1, 2022 Mar 31, 2022
Q4 2021 -39.6 -7.75 -24.4% Oct 1, 2021 Dec 31, 2021
Q3 2021 -35.9 +1.66 +4.42% Jul 1, 2021 Sep 30, 2021
Q2 2021 -33.7 +7.03 +17.3% Apr 1, 2021 Jun 30, 2021
Q1 2021 -29.5 +14.9 +33.6% Jan 1, 2021 Mar 31, 2021
Q4 2020 -31.8 +10.9 +25.5% Oct 1, 2020 Dec 31, 2020
Q3 2020 -37.5 +1.22 +3.15% Jul 1, 2020 Sep 30, 2020
Q2 2020 -40.7 -2.89 -7.64% Apr 1, 2020 Jun 30, 2020
Q1 2020 -44.5 -7.75 -21.1% Jan 1, 2020 Mar 31, 2020
Q4 2019 -42.7 -9.58 -28.9% Oct 1, 2019 Dec 31, 2019
Q3 2019 -38.8 -8.44 -27.8% Jul 1, 2019 Sep 30, 2019
Q2 2019 -37.9 -10.5 -38.4% Apr 1, 2019 Jun 30, 2019
Q1 2019 -36.7 -6.05 -19.7% Jan 1, 2019 Mar 31, 2019
Q4 2018 -33.1 +1.23 +3.58% Oct 1, 2018 Dec 31, 2018
Q3 2018 -30.3 +11.5 +27.6% Jul 1, 2018 Sep 30, 2018
Q2 2018 -27.3 +23.2 +45.8% Apr 1, 2018 Jun 30, 2018
Q1 2018 -30.7 +22 +41.8% Jan 1, 2018 Mar 31, 2018
Q4 2017 -34.3 +22.7 +39.8% Oct 1, 2017 Dec 31, 2017
Q3 2017 -41.8 +14.3 +25.5% Jul 1, 2017 Sep 30, 2017
Q2 2017 -50.5 +1.98 +3.77% Apr 1, 2017 Jun 30, 2017
Q1 2017 -52.7 -4.73 -9.87% Jan 1, 2017 Mar 31, 2017
Q4 2016 -57.1 -8.43 -17.3% Oct 1, 2016 Dec 31, 2016
Q3 2016 -56.2 -4.73 -9.19% Jul 1, 2016 Sep 30, 2016
Q2 2016 -52.5 +4.04 +7.15% Apr 1, 2016 Jun 30, 2016
Q1 2016 -47.9 +10.1 +17.4% Jan 1, 2016 Mar 31, 2016
Q4 2015 -48.6 +9.93 +17% Oct 1, 2015 Dec 31, 2015
Q3 2015 -51.5 +0.94 +1.79% Jul 1, 2015 Sep 30, 2015
Q2 2015 -56.5 -6.15 -12.2% Apr 1, 2015 Jun 30, 2015
Q1 2015 -58 -25 -75.9% Jan 1, 2015 Mar 31, 2015
Q4 2014 -58.6 -27 -85.3% Oct 1, 2014 Dec 31, 2014
Q3 2014 -52.4 -12 -29.5% Jul 1, 2014 Sep 30, 2014
Q2 2014 -50.4 -15.6 -44.9% Apr 1, 2014 Jun 30, 2014
Q1 2014 -33 +34.3 +51% Jan 1, 2014 Mar 31, 2014
Q4 2013 -31.6 +29 +47.9% Oct 1, 2013 Dec 31, 2013
Q3 2013 -40.4 +11.2 +21.6% Jul 1, 2013 Sep 30, 2013
Q2 2013 -34.8 +18.7 +34.9% Apr 1, 2013 Jun 30, 2013
Q1 2013 -67.3 -14.4 -27.2% Jan 1, 2013 Mar 31, 2013
Q4 2012 -60.6 Oct 1, 2012 Dec 31, 2012
Q3 2012 -51.6 Jul 1, 2012 Sep 30, 2012
Q2 2012 -53.4 Apr 1, 2012 Jun 30, 2012
Q1 2012 -52.9 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.